for the Nanoengineering Materials Research Center and developing thermodynamic processing methods for Iron-based

using a novel highly specific small molecule inhibitor of GPR68 named Ogremorphin (OGM) to induce the iron

After a fellowship of the German Research Council (DFG) at the Mayo Clinic, Rochester, MN, he obtained